Our research may provide potential targets for inhibitor development based on the ROS/TXNIP/NLRP3 signaling pathway, which may be useful for future therapeutic studies on neuroinflammation and related neurological diseases. The gene discussed is NLRP3; the disease is nervous system disorder.